Consumers, of course, get the best of both worlds—safe, effective medicine for less than the list price. Talk about a win-win.
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs.
The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without the need for an in-person visit or insurance.
These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications, including heart disease and liver disease. Making it easier for people to access them is a good thing for public health.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Direct-To-Consumer Ozempic Sales Are A Win For Patients And Drug Makers
Sally C. Pipes
Consumers, of course, get the best of both worlds—safe, effective medicine for less than the list price. Talk about a win-win.
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs.
The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without the need for an in-person visit or insurance.
These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications, including heart disease and liver disease. Making it easier for people to access them is a good thing for public health.
Read the op-ed here:
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.